Optimal Dosage of Caspofungin in Critically Ill Patients

Status Completed

Clinical Trial Summary

Intensive care unit (ICU) patients are especially at risk for invasive candidiasis due to the presence of risk factors. It is known that in critically ill patients, alterations in function of various organs and body systems can influence the pharmacokinetics and hence the plasma concentration of a drug. A study of caspofungin in ICU patients has found a high inter- and intra-individual variability in caspofungin concentration. Factors that caused subtherapeutic caspofungin plasma concentrations were body weight > 75 kg and hypoalbuminemia. Furthermore, an efficacy study showed a lower response rate for caspofungin among patients with a higher disease severity score.

As a result of the altered pharmacokinetics, under- or over-exposure of caspofungin can occur in critically ill patients and an adjusted dosage might be necessary in these patients.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01994096
Study type	Interventional
Source	University Medical Center Groningen
Contact
Status	Completed
Phase	Phase 4
Start date	November 2013
Completion date	October 2015

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05539521` - Efficacy and Safety of Remimazolam Besylate Versus Propofol for Sedation in Critically Ill Patients With Deep Sedation	Phase 2
Recruiting	`NCT04776486` - Iohexol Clearance in Critically Ill Patients With Augmented Renal Creatinine Clearance	N/A
Completed	`NCT05766319` - The ICU-recover Box, Using Smart Technology for Monitoring Health Status After ICU Admission	N/A
Recruiting	`NCT03231540` - The PREServation of MUScle Function in Critically Ill Patients (PRESMUS)	N/A
Completed	`NCT02286869` - Cardioventilatory Coupling in Critically Ill Patients	N/A
Completed	`NCT01434823` - 24 Hour Intensivist Coverage in the Medical Intensive Care Unit	N/A
Active, not recruiting	`NCT01142570` - Effect of Enteral Nutrition Enriched in Protein and Based on Indirect Calorimetry Measurement in Chronically Critically Ill Patients	N/A
Completed	`NCT01167595` - Enhanced Protein-Energy Provision Via the Enteral Route in Critically Ill Patients	N/A
Completed	`NCT01293708` - Realities, Expectations and Attitudes to Life Support Technologies in Intensive Care for Octogenarians:
Not yet recruiting	`NCT00916591` - Prokinetic Drugs and Enteral Nutrition	N/A
Recruiting	`NCT00654797` - Improving Blood Glucose Control With a Computerized Decision Support Tool: Phase 2	Phase 2
Withdrawn	`NCT00178321` - Improving Sleep in the Pediatric Intensive Care Unit	N/A
Completed	`NCT01168128` - PERFormance Enhancement of the Canadian Nutrition Guidelines by a Tailored Implementation Strategy: The PERFECTIS Study	N/A
Completed	`NCT02447692` - Proportional Assist Ventilation for Minimizing the Duration of Mechanical Ventilation: The PROMIZING Study	N/A
Recruiting	`NCT04582760` - Early Mobilization in Ventilated sEpsis & Acute Respiratory Failure Study	N/A
Not yet recruiting	`NCT05961631` - Bio-electrical Impedance Analysis Derived Parameters for Evaluating Fluid Accumulation
Completed	`NCT03276650` - Admission of Adult-onset Still Disease Patients in the ICU
Completed	`NCT03922113` - Muscle Function After Intensive Care
Recruiting	`NCT05055830` - Opportunistic PK/PD Trial in Critically Ill Children (OPTIC)
Recruiting	`NCT06027008` - Mechanical Insufflation-Exsufflation (Cough Assist) in Critically Ill Adults	N/A